Young breast cancer patients with early-stage disease may undergo unnecessary testing when diagnosed

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/young-breast-cancer-patients/id4318... . More than one third of younger, early stage breast cancer patients undergo unnecessary imaging procedures – including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM) -- at the time of staging and diagnosis. Carlos Barcenas, M.D., assistant professor, Breast Medical Oncology and Sharon Giordano, M.D., professor, Breast...

Breast cancer – most common cancer in women

submitted by: mdanderson
Download: https://itunes.apple.com/us/itunes-u/breast-cancer-most-common/id4318482... Breast cancer has two main types: ductal carcinoma and lobular carcinoma. These two types of breast cancer present and behave differently but they are treated the same way. Sharon Giordano, M.D., professor in Breast Medical Oncology at The University of Texas MD Anderson Cancer Center and chair of Health Services Research, discusses the differences between ductal and lobular carcinomas including in situ...

Ovarian cancer screening with simple blood test

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/ovarian-cancer-screening-simple/id4... A simple blood test currently approved to detect ovarian cancer disease recurrence is full of new possibility. It may, one day, detect invasive, high-grade disease at its earliest, most curable stage. Listen to Karen Lu, M.D., professor and chair of Gynecologic Oncology and Reproductive Medicine, as she details the findings, and what they could, one day, mean for women.

New bladder cancer screening tool detects more tumors in early stages

submitted by: mdanderson

Blue light cystoscopy (Cysview) reveals more than traditional white light cystoscopy since the bladder cancer cells that become visible in blue light may be invisible with traditional white light. A cystoscopy is a diagnostic procedure used to examine the bladder. Ashish Kamat, M.D., associate professor in Urology at MD Anderson Cancer Center, explains why blue light cystoscopy is so effective in detecting bladder cancer and discusses this disease in general.

New Lung Cancer Screening Offered At MD Anderson

submitted by: mdanderson

Results from national clinical trial mobilizes a team of experts to develop Lung Cancer Screening Program. For appointment contact AskMDAnderson 877-MDA-6789 https://www2.mdanderson.org/sapp/contact/selfreferral/index.cfm

Health care reform and the effect on cancer prevention services

submitted by: mdanderson

Lewis Foxhall, M.D., vice president for Health Policy at The University of Texas MD Anderson Cancer Center, explains ways health care reform supports cancer prevention. This includes health insurance affordability and lower or no-cost cancer prevention services and screenings.

The connection between genes and colon cancer

submitted by: mdanderson

About 20% of colon cancer cases are related to a strong family history of colon cancer. Eduardo Vilar-Sanchez, M.D., Ph.D., Assistant Professor in the Department of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center, focuses his discussion on the main types of genetic colon cancers including hereditary nonpolyposis colorectal cancer syndrome or HNPCC (also called Lynch syndrome) and familial adenomatous polyposis (FAP).

How Decision Aids benefit our patients

submitted by: mdanderson

Dr. Therese Bevers talks about her work with Dr. Robert Volk and the MD Anderson Decision Support Lab to develop decision aids --educational tools that help prepare patients to work with their health care providers to make choices about difficult treatment questions.

PSA Tests How to Interpret Them

submitted by: mdanderson

Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Learn about the different types of PSA tests and how to interpret the results of each.

Making Sense of Hormone Replacement Therapy & Breast Cancer Risk

submitted by: mdanderson
Jennifer Litton M.D. makes sense of hormone replacement therapy and its relationship to your risk of getting breast cancer. Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Dr. Jennifer Litton, Assistant Professor of Breast Medical Oncology, at The University of Texas MD Anderson Cancer Center discusses hormone replacement therapy and breast cancer risk. View other videos at www.mdanderson.org/videos